Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, September 2007, p. 1231-1234, Vol. 14, No. 9
1071-412X/07/$08.00+0 doi:10.1128/CVI.00057-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Dipartimento di Biopatologia e Metodologie Biomediche, Università degli Studi di Palermo, Corso Tukory 211,1 Istituto di Patologia Infettiva e Virologia, Università di Palermo, Piazza Montalto 8, Palermo, Italy,2 Lionex Diagnostics and Therapeutics GmbH, Mascheroder Weg 1b, D-38124 Braunschweig, Germany,3 Department of Oral Medicine and Pathology, KCL Medical and Dental School at Guy's Hospital, London, United Kingdom4
Received 30 January 2007/ Returned for modification 27 February 2007/ Accepted 29 June 2007
Serum responses against Mycobacterium tuberculosis HSP16 were determined for children with tuberculosis (TB) and for healthy purified protein derivative (PPD)-positive and PPD-negative children. Immunoglobulin G (IgG) and IgM responses were higher for TB patients than for other groups. After chemotherapy, IgM and IgG responses decreased for TB patients and PPD-positive subjects. Monitoring of anti-M. tuberculosis HSP16 responses could assist in the management of pediatric TB.
Published ahead of print on 11 July 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»